WallStreetZenWallStreetZen

NASDAQ: INTS
Intensity Therapeutics Inc Stock Forecast, Predictions & Price Target

Analyst price target for INTS

Based on 1 analyst offering 12 month price targets for Intensity Therapeutics Inc.
Min Forecast
$12.00+207.69%
Avg Forecast
$12.00+207.69%
Max Forecast
$12.00+207.69%

Should I buy or sell INTS stock?

Based on 1 analyst offering ratings for Intensity Therapeutics Inc.
Buy
Strong Buy
0 analysts 0%
Buy
1 analysts 100%
Hold
0 analysts 0%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%

Be the first to know when Wall Street analysts revise their INTS stock forecasts and price targets.

INTS stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2024-03-21

1 of 1

INTS vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
INTS$3.90$12.00+207.69%Buy
AVRO$1.19$2.00+68.07%Hold
MLEC$1.42$6.00+322.54%Strong Buy
HCWB$1.40N/AN/A
EQ$1.49$5.00+235.57%Buy

Intensity Therapeutics Stock Forecast FAQ

Is Intensity Therapeutics Stock a good buy in 2024, according to Wall Street analysts?

The consensus among 1 Wall Street analyst covering (NASDAQ: INTS) stock is to Buy INTS stock.

Out of 1 analyst, 0 (0%) are recommending INTS as a Strong Buy, 1 (100%) are recommending INTS as a Buy, 0 (0%) are recommending INTS as a Hold, 0 (0%) are recommending INTS as a Sell, and 0 (0%) are recommending INTS as a Strong Sell.

If you're new to stock investing, here's how to buy Intensity Therapeutics stock.

What is INTS's Price Target?

According to 1 Wall Street analyst that have issued a 1 year INTS price target, the average INTS price target is $12.00, with the highest INTS stock price forecast at $12.00 and the lowest INTS stock price forecast at $12.00.

The Wall Street analyst predicted that Intensity Therapeutics's share price could reach $12.00 by Mar 21, 2025. The average Intensity Therapeutics stock price prediction forecasts a potential upside of 207.69% from the current INTS share price of $3.90.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.